Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neurophil leukocyte elastase and cathepsin G

Thrombosis and Haemostasis

Volumn 75, Issue 1, 1996, Pages 140-146

  Kolev, Krasimir ^a   Komorowicz, Erzsébet ^a   Owen, Whyte G ^b   Machovich, Raymund ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIPLASMIN; CALCIUM ION; CATHEPSIN G; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOLYTIC AGENT; LEUKOCYTE ELASTASE; PLASMIN; SYNTHETIC PEPTIDE;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CROSS LINKING; FIBRIN POLYMERIZATION; FIBRINOLYSIS; GEL FILTRATION; HUMAN; KRINGLE DOMAIN; PRIORITY JOURNAL; SPECTROPHOTOMETRY; TURBIDIMETRY;

EID: 0030051895     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650234     Document Type: Article

References (47)

1. Bachmann F. Fibrinolysis. In: Thrombosis and Haemostasis. Verstraete M, Vermylen J, Lijnen HR, Arnout I, eds. Leuven University Press, Leuven 1987; pp. 227-65.
2. Zahn FW. Untersuchungen uber Thrombose. Bildung der Thromben. Virchow's Arch Path Anat 1875; 62: 82-132.
3. Opie EL. Experimental pleurisy. J Exp Med 1907; 9: 391-413.
4. Plow EF. The major fibrinolytic proteases of human leukocytes. Biochim Biophys Acta 1980; 630: 47-56.
5. Machovich R, Owen WG. The elastase-mediated pathway of fibrinolysis. Blood Coagul Fibrinolysis 1990; 1: 79-90.
6. Niewiarowski S, Regoeczi E, Mustard JF. Platelet interaction with fibrinogen and fibrin: comparison of the interaction of platelets with that of fibroblasts, leukocytes and erythrocytes. Ann NY Acad Sci 1972; 201: 72-83.
7. Loike JD, Sodeik B, Cao L, Leucona S, Weitz JI, Detmers PA, Wright SD, Silverstein SC. CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the Aα chain of fibrinogen. Proc Natl Acad Sci USA 1991; 88: 1044-8.
8. Machovich R, Owen WG. An elastase-dependent pathway of plasminogen activation. Biochemistry 1989; 28: 4517-22.
9. Machovich R, Himer A, Owen WG. Neutrophil proteases in plasminogen activation. Blood Coagul Fibrinolysis 1990; 1: 273-7.
10. Markus G, DePasquale JL, Wissler FC. Quantitative determination of the binding of ∈-aminocaproic acid to native plasminogen. J Biol Chem 1978; 253: 733-9.
11. Menhart N, McCance SG, Sehl LC, Castellino FJ. Functional independence of the kringle 4 and kringle 5 regions of human plasminogen. Biochemistry 1993; 32: 8799-806.
12. Christensen U. The AH-site of plasminogen and two C-terminal fragments. A weak lysine-binding site preferring ligands not carrying a free carboxylate function. Biochem J 1984; 223: 413-21.
13. Wu HL, Chang BI, Wu DH, Chang LC, Gong CC, Lou KL, Shi GY. Interaction of plasminogen and fibrin in plasminogen activation. J Biol Chem 1990; 265: 19658-64.
14. Plow EF, Gramse M, Havemann K. Immunochemical discrimination of leukocyte elastase from plasmic degradation products of fibrinogen. J Lab Clin Med 1983; 102: 858-69.
15. Morris JP, Blatt S, Powell JR, Strickland DK, Castellino FJ. Role of lysine binding regions in the kinetic properties of human plasmin. Biochemistry 1981; 20: 4811-6.
16. Ney KA, Pizzo SV. Fibrinolysis and fibrinogenolysis by Val442-plasmin. Biochim Biophys Acta 1982; 708: 218-24.
17. Suenson E, Bjerrum P, Holm A, Lind B, Melda M, Selmer J, Petersen LC. The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation. J Biol Chem 1990; 265: 22228-37.
18. McKee PA, Mattock P, Hill RL. Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. Proc Natl Acad Sci USA 1970; 66: 738-44.
19. McDonagh RP, McDonagh J, Duckert F. The influence of fibrin crosslinking on the kinetics of urokinase-induced clot lysis. Br J Haematol 1971; 21: 323-32.
20. Carmassi F, Cardinali M, Bianchi R, Chung SI. Influence of factor XIII-mediated crosslinking on fibrinolysis by leukocyte elastase. Fibrinolysis 1991; 3: 45-52.
21. Edwards MW, de Bang E, Strout J, Bishop PD. Recombinant factor XIII supplemented clots resist lysis by plasmin and leukocyte elastase. Fibrinolysis 1993; 7: 211-6.
22. Purves LR, Lindsey GG, Brown G, Franks J. Stabilization of the plasmin digestion products of fibrinogen and fibrin by calcium ions. Thromb Res 1978; 12: 473-84.
23. Nieuwenhuizen W, Voskuilen M, Vermond A, Haverkate F, Hermans J. A fibrinogen fragment D (D intermediate) with calcium binding but without anticlotting properties. Biochim Biophys Acta 1982; 707: 190-2.
24. 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest 1980; 65: 290-7.
25. Reed III GL, Matsueda GR, Haber E. Synergistic fibrinolysis: combined effects of plasminogen activators and antibody that inhibits alpha 2-antiplasmin. Proc Natl Acad Sci USA 1990; 87: 1114-8.
26. 1-inactivator by human polymorphonuclear leukocyte elastase. J Biol Chem 1982; 257: 9849-54.
27. 2-antiplasmin. J Biol Chem 1987; 262: 6055-9.
28. Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095-6.
29. Kolev K, Léránt I, Tenekejiev K, Machovich R. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin and miniplasmin by plasma protease inhibitors. J Biol Chem 1994; 269: 17030-4.
30. 1-protease inhibitor reactive site. J Biol Chem 1979; 254: 4027-32.
31. Schwartz ML, Pizzo SV, Hill RL, McKee PA. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. J Clin Invest 1971; 50: 1506-13.
32. Segel LA. On the validity of the steady state assumption of enzyme kinetics. Bull Mathem Biol 1988; 50: 579-93.
33. De Cristofaro R, Di Cera E. Modulation of thrombin-fibrinogen interaction by specific ion effects. Biochemistry 1992; 31: 257-65.
34. Carr ME, Gabriel DA. The effect of dextran 70 on the structure of plasma-derived fibrin gels. J Lab Clin Med 1980; 96: 985-93.
35. Jones AJS, Meunier AM. A precise and rapid microtitre plate clot lysis assay; Methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis. Thromb Haemost 1990; 64: 455-63.
36. Carr ME, Powers PL, Jones MR. Effects of Poloxamer 188 on the assembly, structure and dissolution of fibrin clots. Thromb Haemost 1991; 66: 565-8.
37. Nishino N, Kakkar VV, Scully MF. Influence of intrinsic and extrinsic plasminogen upon the lysis of thrombi in vitro. Thromb Haemost 1991; 66: 672-7.
38. Carr ME, Krishnamurti C, Alving BM. Effect of plasminogen activator inhibitor-1 on tissue-type plasminogen activator-induced fibrinolysis. Thromb Haemost 1992; 67: 106-10.
39. Gaffney PJ. The fibrinolytic system. In: Haemostasis and Thrombosis. Bloom AL. Thomas DP, eds. Churchill Livingstone, NY. 1981; pp 198-224.
40. Pizzo SV, Schwartz ML, Hill RL, McKee PA. The effect of plasmin on the subunit structure of human fibrinogen. J Biol Chem 1972; 247: 636-45.
41. Pizzo SV, Schwartz ML, Hill RL, McKee PA. The effect of plasmin on the subunit structure of human fibrin. J Biol Chem 1973; 248, 4574-83.
42. Shen LL, McDonagh RP, Hermans J. Early events in the plasmin digestion of fibrinogen and fibrin. Effects on fibrin polymerization. J Biol Chem 1977; 252: 6184-9.
43. Liu CY, Sobel JH, Weitz JI, Kaplan KL, Nossel HL. Immunologic identification of the cleavage products from the Aα- and Bα-chains in the early stages of plasmin digestion of fibrinogen. Thromb Haemost 1986; 56: 100-6.
44. Müller E, Henschen A. Isolation and characterization of early plasmic degradation products of fibrinogen by high-performance liquid chromatography. In: Fibrinogen and Its Derivatives. Müller-Berghaus G, Scheefers-Borchel U, Selmayer E, Menschen A, eds. Excerpta Medica, Amsterdam 1986; pp 327-30.
45. 1-proteinase inhibitor deficiency. J Clin Invest 1986; 78: 155-62.
46. Gramse M, Bingenheimer C, Havemann K. Degradation of human fibrinogen by chymotrypsin-like neutral protease from human granulocytes. Thromb Res 1980; 19: 201-9.
47. Kolev K, Komorowicz E, Machovich R. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors. Blood Coagul Fibrinolysis 1994; 5: 905-11.